Mohd Zaki Salleh

Mohd Zaki Salleh


Summary

Mohd Zaki Salleh is currently working at the Integrative Pharmacogenomics Institute, Universiti Teknologi MARA. He is the founding Director of the research institute which focuses on research on precision medicine using genomic as the platform.
Before joining Universiti Teknologi MARA, he had served as a lecturer in Universiti Sains Malaysia and Universiti Kebangsaan Malaysia. He is the editor and reviewer for some journals.

Data Mining & Machine Learning Genetics Genomics Public Health

Work details

Director Research Institute

Universiti Teknologi MARA
January 2007
Integrative Pharmacogenomics Institute
The Integrative Pharmacogenomics Institute (iPROMISE) is one of the seven (7) centres of excellence (CoE) in UiTM which was established since June 2013. It was previously known as Pharmacogenomics Centre (PROMISE) with Prof. Dato' Dr. Mohd. Zaki Salleh as the Founding Head in 2008 and was appointed as the Director in 2011. The goal of iPROMISE is to become a centre of excellence in conducting and translating cutting edge researches to achieve and enhance Precision Medicine. In 2015, iPROMISE has merged with the Non-Destructive Biomedical and Pharmaceutical Research Centre (NDBPRC). To accommodate this development and to encourage specialization of its researchers, the institute gave rise to two new centres under its wing; the Integrative Systemic Biology Centre (ISBC), and the Bioinformatics centre. It is the mission of iPROMISE to ensure the conduct of high quality researches and services in enhancing and accelerating researches. The institute adopts the belief of sharing its experties and facilities with other institutions and industries in order to create and improve linkages and collaborations in research. In addition, the institute has emphasized its efforts to enhance current innovations and services in the relevant fields. After years of sustained performance, iPROMISE has been granted the BionNexus Centre of Excellence award under the BioNexus Partnering Programme by the Malaysian Biotech Corporation (MBC) in 2011, and this partnership is ongoing.

Websites